Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Vaccines

  Free Subscription


12.08.2019

3 Clin Infect Dis
1 Infect Immun
1 J Virol
1 Lancet Child Adolesc Health
1 Pediatrics
1 PLoS Med
2 PLoS One
1 Science
12 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Infect Dis

  1. LEROUX-ROELS G, Bebia Z, Maes C, Aerssens A, et al
    Safety and immunogenicity of a second dose of an investigational maternal trivalent Group B streptococcus vaccine in non-pregnant women 4-6 years after a first dose: results from a phase 2 trial.
    Clin Infect Dis. 2019 Aug 8. pii: 5545276. doi: 10.1093.
    PubMed     Text format     Abstract available

  2. MEDER KN, Jayasinghe S, Beard F, Dey A, et al
    Long-term impact of pneumococcal conjugate vaccines on invasive disease and pneumonia hospitalisations in Indigenous and non-Indigenous Australians.
    Clin Infect Dis. 2019 Aug 7. pii: 5544590. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. WIESE AD, Grijalva CG
    To boost or not to boost? Lessons from the Australian pneumococcal conjugate vaccination program.
    Clin Infect Dis. 2019 Aug 7. pii: 5544622. doi: 10.1093.
    PubMed     Text format    


    Infect Immun

  4. BEAUDET J, Tulman ER, Pflaum K, Canter JA, et al
    Immunologic Pathways in Protective versus Maladaptive Host Responses to Attenuated and Pathogenic Strains of Mycoplasma gallisepticum.
    Infect Immun. 2019;87.
    PubMed     Text format     Abstract available


    J Virol

  5. DHAKAL S, Klein SL
    Host factors impact vaccine efficacy: implications for seasonal and universal influenza vaccine programs.
    J Virol. 2019 Aug 7. pii: JVI.00797-19. doi: 10.1128/JVI.00797.
    PubMed     Text format     Abstract available


    Lancet Child Adolesc Health

  6. HALSTEAD SB, Dans LF
    Dengue infection and advances in dengue vaccines for children.
    Lancet Child Adolesc Health. 2019 Aug 1. pii: S2352-4642(19)30205.
    PubMed     Text format     Abstract available


    Pediatrics

  7. HOFSTETTER AM, Jacobson EN, deHart MP, Englund JA, et al
    Early Childhood Vaccination Status of Preterm Infants.
    Pediatrics. 2019 Aug 7. pii: peds.2018-3520. doi: 10.1542/peds.2018-3520.
    PubMed     Text format     Abstract available


    PLoS Med

  8. OKALA SG, Darboe MK, Sosseh F, Sonko B, et al
    Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia.
    PLoS Med. 2019;16:e1002854.
    PubMed     Text format     Abstract available


    PLoS One

  9. SCHMEDT N, Schiffner-Rohe J, Sprenger R, Walker J, et al
    Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany.
    PLoS One. 2019;14:e0220848.
    PubMed     Text format     Abstract available

  10. BENNASRALLAH C, Kacem M, Dhouib W, Zemni I, et al
    BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0219991.
    PubMed     Text format     Abstract available


    Science

  11. TOKATLIAN T, Read BJ, Jones CA, Kulp DW, et al
    Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers.
    Science. 2018 Dec 20. pii: science.aat9120. doi: 10.1126/science.aat9120.
    PubMed     Text format     Abstract available


    Vaccine

  12. STARK FC, Akache B, Ponce A, Dudani R, et al
    Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30888.
    PubMed     Text format     Abstract available

  13. HASSAN WS, Giaretta PR, Rech R, Ollivault-Shiflett M, et al
    Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease.
    Vaccine. 2019 Aug 3. pii: S0264-410X(19)31013.
    PubMed     Text format     Abstract available

  14. NOH JY, Jang YS, Lee SN, Choi MJ, et al
    Randomized, single-blind, active-controlled phase I clinical trial to evaluate the immunogenicity and safety of GC3114 (high-dose, quadrivalent influenza vaccine) in healthy adults.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30997.
    PubMed     Text format     Abstract available

  15. CHEN CH, Su LH, Li HC, Hsu MH, et al
    Evaluation of the impact of 13-valent pneumococcal conjugate vaccine immunization in children by surveillance of culture-confirmed pneumococcal disease: A prospective clinical microbiological study.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30994.
    PubMed     Text format     Abstract available

  16. YAN R, He H, Zhou Y, Xie S, et al
    Study on factors associated with seroprotection after measles vaccination in children of 6-14years in Eastern China.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30996.
    PubMed     Text format     Abstract available

  17. WILDER-SMITH A, Smith PG, Luo R, Kelly-Cirino C, et al
    Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30894.
    PubMed     Text format     Abstract available

  18. RAY A, Sarkar K, Haldar P, Ghosh R, et al
    Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)31003.
    PubMed     Text format     Abstract available

  19. PASSWELL JH, Ashkenazi S, Banet-Levi Y, Ramon-Saraf R, et al
    Erratum to 'Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children' [Vaccine 28 (2010) 2231-2235].
    Vaccine. 2019 Aug 1. pii: S0264-410X(19)30986.
    PubMed     Text format    

  20. GERRITZEN MJH, Salverda MLM, Martens DE, Wijffels RH, et al
    Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30161.
    PubMed     Text format     Abstract available

  21. CHEN TH, Liu WC, Chen IC, Liu CC, et al
    Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30247.
    PubMed     Text format     Abstract available

  22. ROMIJNDERS KAGJ, van Seventer SL, Scheltema M, van Osch L, et al
    A deliberate choice? Exploring factors related to informed decision-making about childhood vaccination among acceptors, refusers, and partial acceptors.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30968.
    PubMed     Text format     Abstract available

  23. ROSS TM, DiNapoli J, Giel-Moloney M, Bloom CE, et al
    Corrigendum to "A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains" [Vaccine 37 (2019) 2369-2376].
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30966.
    PubMed     Text format    


    Virology

  24. WANG X, Fang Z, Xiong J, Yang K, et al
    A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge.
    Virology. 2019;536:32-38.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: